RecruitingNot Applicable

Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

Denmark150 participantsStarted 2015-05

Plain-language summary

Although recommended therapy for patients with ST-segment elevation myocardial infarction is primary PCI, it remains unestablished whether patients with a symptom duration of more 12 hours benefit from acute revascularisation. This study aims to investigate whether acute intervention is superior to subacute intervention in these patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Inclusion criteria: * Patients more than 18 years of age. * STEMI \> 12 hours and \< 36 hours. * Clinical stable, i.e. no on going angina, hemodynamically stable (systolic BP \> 90) and Killip class \< 3. Exclusion Criteria: * Clinical instability which requires an acute invasive strategy. * Left main occlusion or multivessel disease which requires CABG. * Previous Q-wave infarction in the current infarct related artery. * Left Bundle Branch Block (LBBB). * Severe renal insufficiency. * Pacemaker * Chronic atrial fibrillation. * Previous Coronary Artery Bypass Surgery (CABG). * Pregnancy. * Other severe illness with life expectancy less than 1 year

What they're measuring

Acute salvage index evaluated by MRI

Timeframe: 1-2 days

Trial details

NCT IDNCT02445885

SponsorThomas Engstrom

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-30

Contact for this trial

Lars Nepper-Christensen, MD

+4535457586 lars.nepper@gmail.com

View on ClinicalTrials.gov More Ischemic Heart Disease trials